Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's Disease

BACKGROUND: The efficacy of adalimumab in inducing and maintaining remission in children with moderately to severely active Crohn's disease was shown in the IMAgINE 1 trial (NCT00409682). As per protocol, nonresponders or patients experiencing flare(s) on every other week (EOW) maintenance dosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubinsky, Marla C., Rosh, Joel, Faubion, William A., Kierkus, Jaroslaw, Ruemmele, Frank, Hyams, Jeffrey S., Eichner, Samantha, Li, Yao, Huang, Bidan, Mostafa, Nael M., Lazar, Andreas, Thakkar, Roopal B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Original Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794130/
https://www.ncbi.nlm.nih.gov/pubmed/26950307
http://dx.doi.org/10.1097/MIB.0000000000000715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794130/
https://www.ncbi.nlm.nih.gov/pubmed/26950307
http://dx.doi.org/10.1097/MIB.0000000000000715

Ejemplares similares